INTERNATIONAL PATENT: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD., 长春金赛药业有限责任公司 FILES APPLICATION FOR "FUSION PROTEIN CAPABLE OF BLOCKING ACTION OF BAFF AND APRIL ON RECEPTOR THEREOF"

GENEVA, Feb. 23 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2025/114430) for "FUSION PROTEIN CAPABLE OF BLOCKING ACTION OF BAFF AND APRIL ON RECEPTOR THEREOF" on Aug 13, 2025. With publication no. WO/2026/037338, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed...